P3 AI: Package Insert and Label Information
P3 AI- hydrolyzed soy protein (enzymatic; 2000 mw) and glycerin gel
CONTRAD SWISS
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Glycerine
Hydrolyzed Soy Protein
Purpose
Skin Protectant
Uses
Pre and post regenerative skin protectant topical
Pain reliever aid. Eases discomfort associated with inflammation of joints, tendons and nerves
Apply the monodose gel on a patch gauze to clean dry skin. Place the patch on the affected area. Wear the patch for 4-8 hours.
Warnings
For External Use Only
Do not use other creams or cosmetics with the monodose.
Do not get the area wer once the patch is in place.
Avoid Contact with Eyes
Stop Use and Ask the Doctor if:
- Condition Worsens
- Symptoms last more than 7 days
Keep Out Reach of Children
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Apply as needed.
- Children under 6 months: ask a doctor
Apply the monodose gel on a patch gauze to clean dry skin. Place the patch on the affected area. Wear the patch for 4-8 hours.
Other Information
Store at room temperature 20-25◦C (68-77◦F) in a dry place, out of direct sunlight.
Inactive Ingredients
Aqua, Benzoic acid, Carbomer, Dehydroacetic acid, Disodium EDTA, Ethylhexylglycerin, Panthenol, PEG-40 hydrogenated castor oil, Phenoxyethanol, Propylene glycol, Sodium hyaluronate, Sodium hydroxide, Xanthan gum
Questions?
@ info@contrad.ch
To report suspected adverse reactions contact 1-800-332-1088
Package. Label Principal Display Panel
P3 AI p3 ai gel | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
|
Labeler — CONTRAD SWISS (486203529) |
Registrant — CONTRAD SWISS (486203529) |
Establishment | |||
Name | Address | ID/FEI | Operations |
SIPRES SRL | 440712842 | manufacture (72582-001) |
Establishment | |||
Name | Address | ID/FEI | Operations |
CONTRAD SWISS | 486203529 | label (72582-001) |
Revised: 01/2021 CONTRAD SWISS
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.